“ There is a huge interest now for healthcare data analysis to better protect people from the effects of the [corona]virus. This is really opening new doors,… ”
In Conversation
“ As insurers, we want to see fair and affordable pricing, and we are willing to pay the “right price” for the right therapies that bring value… ”
Susan M. Gasser – Director Emeritus & Group Leader, Friedrich Miescher Institute for Biomedical Research (FMI), Switzerland
“ Europe has the tools to advance in both basic and translational research but on the latter, it perhaps needs to simplify its processes and expand both… ”
“ We have a very strong R&D team at ADC Therapeutics that has been able to file – on average – two INDs per year since 2012 ”
“ I predict that we will observe [pharma] manufacturing coming back to Europe, and Ticino will play a role in that ”
“ A CDMO does not really innovate. We leave that task of research to our excellent customers. What we do well is stay on top of manufacturing… ”
“ We position ourselves as a pure play, differentiated, fully vertically integrated biosimilars development and manufacturing company that goes global with partners that are regional champions ”
“ When you have started two companies, people think that you like risk. In fact, I hate risk and have tried to avoid it my entire life ”
“ We have been on a high-speed train, transforming AbbVie into an agile and high-performing organization, capable of launching a series of new treatments across multiple indications ”
“ Middle Eastern customers hold Switzerland and its pharmaceutical industry in high esteem. Manufacturing products in Switzerland also ensures that they are of the highest quality ”
“ A concrete example of Pfizer Norway’s value is our pioneering of digital channels and how we utilize these channels to communicate with physicians and the public ”
“ The uniqueness of Synbias lies in the constant innovation that the company is able to implement in its manufacturing processes ”